Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk! [PDF]
Medicina, 2023 Activated partial thromboplastin time (aPTT) is a fundamental screening test for coagulation disturbances. An increased aPTT ratio is quite common in clinical practice.
Rita Carlotta Santoro +3 more
doaj +2 more sources
The partial thromboplastin (cephalin) time test [PDF]
Journal of Clinical Pathology, 1972 Nine partial thromboplastin (cephalin) reagents have been compared in a parallel investigation of groups of patients on `long-term' anticoagulants, a group with moderate haemophilia, and patients on heparin infusion.Results with the seven commercial reagents and a human cephalin extract have been correlated with those of a specially prepared and ...
L. Poller, J M Thomson
openalex +5 more sources
CA125-Associated Activated Partial Thromboplastin Time and Thrombin Time Decrease in Patients with Adenomyosis [PDF]
Journal of Multidisciplinary HealthcareFanchun Yang, Qingying Wang, Rui Ma, Fangzhen Deng, Jie Liu Department of Obstetrics and Gynecology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, People’s Republic of ChinaCorrespondence: Jie Liu, Department of ...
Yang F, Wang Q, Ma R, Deng F, Liu J
doaj +2 more sources
CA125-Associated Activated Partial Thromboplastin Time and Thrombin Time Decrease in Patients with Adenomyosis [Letter] [PDF]
Journal of Multidisciplinary HealthcareZainarda,1,2,* Hasta Handayani Idrus3,* 1Faculty of Medicine, Hasanuddin University, Makassar, Indoensia; 2Department of Orthopedic, Dody Sarjoto Hospital, Makassar, Indoensia; 3Biomedical Research Center, Research Organization for Health ...
Zainarda, Idrus HH
doaj +2 more sources
The Effect of Sugammadex on Prothrombin and Activated Partial Thromboplastin Time. [PDF]
Cureus, 2021 Sugammadex is routinely used as an effective neuromuscular blockade reversal agent. Several studies have indicated that it may prolong the prothrombin time (PT) and the activated partial thromboplastin time (aPTT). This review gathers the relevant in vivo studies to accumulate knowledge on the subject. Nine studies were included.
Samara E +3 more
europepmc +5 more sources
Risk stratification and prognostic value of prothrombin time and activated partial thromboplastin time among COVID-19 patients. [PDF]
PLoS ONE, 2022 BackgroundCOVID-19 is a viral disease caused by a new strain of corona virus. Currently, prognosis and risk stratification of COVID-19 patients is done by the disease's clinical presentation.
Esayas Tekle +8 more
doaj +2 more sources
The multiple faces of the partial thromboplastin time APTT [PDF]
Journal of Thrombosis and Haemostasis, 2004 Samuel I. Rapaport +7 more
+11 more sources
The partial thromboplastin time: defining an era in coagulation [PDF]
Journal of Thrombosis and Haemostasis, 2003 G C White
openalex +5 more sources
Potential Anticoagulant Activity of Thymus atlanticus Leaves Part in vitro on Normal Plasma Samples [PDF]
International Journal of Biomedicine, 2022 The purpose of this study was to evaluate the anticoagulant activity of Thymus atlanticus leaves. Methods and Results: This cross-sectional study was carried out in Khartoum state from March 2021 to June 2021. This study comprised 60 healthy volunteers (
Mothana Abdullah Elhussein +3 more
doaj +1 more source
Majalah Kedokteran Andalas, 2021 Pendahuluan: Hematokrit (Ht) yang tinggi merupakan salah satu faktor interferensi pemeriksaan hemostasis yang sering luput dari perhatian. Penurunan volume plasma relatif terhadap keseluruhan darah pada hematokrit yang tinggi akan meningkatkan rasio ...
Hevrina Yufani, Zelly Dia Rofinda
doaj +1 more source